Making Medicine Personal

Image: Erica P. Johnson "Never share your prescription." That's good advice: People may react differently to drugs, whether because of weight, gender, or metabolic differences. When a physician writes a prescription, one would think that it is custom-made for the patient. But, more often than not, it's "Take two and call me in the morning." Advocates of pharmacogenomics say a better approach would be to custom-design medications to fit each patient's needs; some scientists argue, however, that

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

"Never share your prescription." That's good advice: People may react differently to drugs, whether because of weight, gender, or metabolic differences. When a physician writes a prescription, one would think that it is custom-made for the patient. But, more often than not, it's "Take two and call me in the morning." Advocates of pharmacogenomics say a better approach would be to custom-design medications to fit each patient's needs; some scientists argue, however, that the data are simply too complex to accomplish this.

Pharmacogenomics is the study of how genetic variation influences individual responses, including metabolism and biological outcome, to a given drug or class of drugs. The field holds promise for both drug developers and patients; the latter could benefit from improved efficacy and diminished side effects. According to Rochelle Long, chief of the pharmacological and physiological sciences branch, National Institute of General Medical Sciences (NIGMS), Bethesda, Md., physicians tend ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Aileen Constans

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours